Table 4

Frequency of FFLL and FfLL genotypes versus all other FokI and poly(adenylate) combinations

Control nTotal cancer patients, nOdds ratio (95% CI)Odds ratio* (95% CI)Odds ratio (95% CI)
FFLL or FfLL1091531.82 (1.35–2.45)1.99 (1.44–2.75)2.13 (1.52–2.99)
All other FokI/poly(adenylate) combinations3182451.001.001.00
Total427398
  • * Adjusted odds ratio for age (of controls at sampling and cases at diagnosis), HRT usage, and menopausal status.

  • Adjusted odds ratio for age (of controls at sampling and cases at sampling), HRT usage, and menopausal status.

  • P < 0.001; statistically significant.